Geneos Wealth Management’s T. Rowe Price US Equity Research ETF TSPA Stock Holding History

Geneos Wealth Management’s Portfolio TSPA Stock Details TSPA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.4M	Buy	498,791 +2,161	+0.4%	+$92.3K	0.47%	46
2025 Q4	$21.2M	Buy	496,630 +17,736	+4%	+$754K	0.52%	40
2025 Q3	$20.1M	Buy	478,894 +9,980	+2%	+$402K	0.51%	40
2025 Q2	$18.2M	Sell	468,914 -486,049	-51%	-$17.5M	0.45%	48
2025 Q1	$33.6M	Buy	954,963 +954,731	+411,522%	+$35.4M	0.48%	41
2024 Q4	$8.58K	Buy	+232	New	+$8.61K	﹤0.01%	2110

Other funds holding TSPA

National Pension Service Jeonju-Si, Jeollabuk-Do, South Korea $132B AUM 28.96% 1-Year Est. Return

M&T Bank Buffalo, New York $29.2B AUM 22.81% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

FMWA

Forvis Mazars Wealth Advisors Springfield, Missouri $5.27B AUM 18.06% 1-Year Est. Return

PWM

Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

AFA

Alpha Financial Advisors Charlotte, North Carolina $326M AUM 15.49% 1-Year Est. Return

FNT

First National Trust Hermitage, Pennsylvania $2.93B AUM 22.18% 1-Year Est. Return

Geneos Wealth Management's TSPA Position: Q1 2026 in Review

Geneos Wealth Management increased its T. Rowe Price US Equity Research ETF (TSPA) stake by 0.44% in Q1 2026, buying an estimated $92.3K and bringing the position to 498,791 shares worth $20.4M. The position accounts for 0.47% of the portfolio, ranked #46.

Geneos Wealth Management first reported a position in TSPA in Q4 2024 and has held it in 6 quarters since. The position peaked at $33.6M in Q1 2025. 119 funds tracked by Wall St. Rank hold TSPA as of Q1 2026.

Geneos Wealth Management held 498,791 shares of T. Rowe Price US Equity Research ETF worth $20.4M as of Q1 2026.
Geneos Wealth Management bought 2,161 T. Rowe Price US Equity Research ETF shares in Q1 2026, an estimated $92.3K.
T. Rowe Price US Equity Research ETF made up 0.47% of Geneos Wealth Management's portfolio in Q1 2026, its #46 holding.
Geneos Wealth Management first reported a position in T. Rowe Price US Equity Research ETF in Q4 2024 and has held it in 6 quarters since.
Geneos Wealth Management's T. Rowe Price US Equity Research ETF position peaked at $33.6M in Q1 2025.
119 funds tracked by Wall St. Rank held T. Rowe Price US Equity Research ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.